Skip to content

Singapore Cohort of Patients with Advanced Heart Failure

Singapore Cohort of Patients with Advanced Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03089034
Acronym
SCOPAH
Enrollment
300
Registered
2017-03-24
Start date
2017-07-24
Completion date
2025-10-31
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Brief summary

Chronic Heart Failure (CHF) is one of the leading causes of death in Singapore. Although it is well established that CHF patients in Singapore are less likely to be referred to palliative care services than cancer patients, little data is available on end-of-life (EOL) experience of advanced CHF patients in Singapore, including the inter-relationships between patient decision-making, quality of life trajectories, and health and cost consequences.

Detailed description

To address this gap and to identify areas for better delivery of end-of-life services to patients with advanced CHF, the investigators propose to enrol a cohort of 300 patients with advanced CHF (New York Heart Association class III and IV), survey the participants every 4 months for a period of two years or till they die, whichever is earlier. The goal of this cohort study is to better understand the relationship between patient preferences, health care access, utilization, costs, and quality of life, and to identify strategies to improve the EOL experience for these patients. It is also important to recognize the significant role of the family in medical decision making in Asia. Previous studies from Singapore reveal that patients want their families to be involved in the decision making process. The role of the family in decision making is consistent with the Chinese culture of interdependency, obligations and filial piety. Decisions regarding treatment are often made by family caregivers, sometimes with little or no input from patients. Given this reality, the investigators will also enroll caregivers of the patients to evaluate their role in decision making for treatment of patients.

Interventions

None listed

Sponsors

Singapore General Hospital
CollaboratorOTHER
National Heart Centre Singapore
CollaboratorOTHER
Duke-NUS Graduate Medical School
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(patients): * Age ≥ 21 years old * Singaporean or Singapore Permanent Resident * Diagnosis of advanced Congestive Heart Failure (New York Heart Association Class III and IV). * Intact cognition (of patients ≥60 years of age) as determined by the Montreal Cognitive Assessment. If patient fails the cognitive test, he/she continues to be eligible for the study although self-reported data will no longer be collected. The primary informal caregiver of the patient will be approached for providing consent on behalf of the patient, to allow access to review of patient's medical and billing records The inclusion criteria (primary informal caregivers) * Age ≥ 21 years old * Main person or one of the main providing care to the patient (e.g. accompanying patient for doctor's visits, helping the patient with day to day activities) * Main person or one of the main ensuring provision of care (e.g. supervision of foreign domestic worker so that the patient is looked after) * Main person or one of the main involved in making decisions regarding treatment the patient receives * Patient they are caring for is enrolled in the study The inclusion criteria (physicians) • Patients they are treating are enrolled in the study

Exclusion criteria

(patients): * Patients who are not Singaporeans or Singapore Permanent Residents * Patients who are ≤21 years of age * Patients with psychiatric or cognitive disorders

Design outcomes

Primary

MeasureTime frameDescription
Change in patients' cognitive statusFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess patients' cognitive status through Montreal Cognitive Assessment
Change in activities of daily living among patients through the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess limitations in activities of daily living of patients through OARS Multidimensional Functional Assessment Questionnaire
Change in patient's perceived quality of care during the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will describe patients' assessment of their own care using a scale used by Ayanian et al (JCO, 2010) that consists of 13 questions.
Change in patient's compliance with treatment regimens and self-care behavioursFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months,24 months)Investigators will describe patients' compliance with their self-care behaviour using the Self Care of Heart Failure Index (SCHFI)
Total health care expenditure during the last year of life through analysis of medical billsFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investogators will calculate total health care expenditure during the last year of patient's life as the sum total of expenditures incurred at clinics etc
Change in overall quality of life among patients through the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess patient's quality of life through FACT-G Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months)
Change in distress among patients through the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess patients' distress through the distress thermometer

Secondary

MeasureTime frameDescription
Change in caregiver burden through the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess caregiver burden through modified Caregiver Reaction Assessment Scale Instrument
Change in caregiver's level of emotional distress through the last year of lifeFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)Investigators will assess caregiver's anxiety and depression through the Hospital Anxiety and Depression Scale (HADS).
Caregiver's perception of patient's end-of-life care assessed after patient's death8 weeks bereavementInvestigators will assess caregiver perceived quality of end-of-life care through CEQUEL.
Change in patient's awareness of hospice palliative care services among heart failure patientsFrom recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months )Investigators will assess change in patients' awareness of hospice palliative care services by asking them if they are aware and are using hospice palliative care services.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026